Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety

Beijing Dongfang Biotech Co., Ltd. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
nsclc
nsclc, late or metastatic non-squamous non-small cells, egfr mutations patients, cell lung cancer., interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 887412
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.